Clinical Trial Update: Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Pangramin SLIT HDM-mix for house dust mite-induced allergic rhinitis. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Pangramin SLIT HDM-mix

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2016-04-29